Jones Hill Capital’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-233,808
Closed -$19.4M – 36
2026
Q2
$19.4M Sell
233,808
-84,783
-27% -$6.8M 4.11% 10
2026
Q1
$24.5M Hold
318,591
– – 5.25% 8

Other funds holding ANIP

Jones Hill Capital's ANIP Position: Q3 2026 in Review

Jones Hill Capital sold out of ANI Pharmaceuticals (ANIP) in Q3 2026, closing a stake of 233,808 shares — an estimated $19.4M sold.

Jones Hill Capital first reported a position in ANIP in Q1 2026 and held it in 2 quarters. The position peaked at $24.5M in Q1 2026. 291 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Jones Hill Capital reported no remaining ANI Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Jones Hill Capital sold 233,808 ANI Pharmaceuticals shares in Q3 2026, an estimated $19.4M.
  • Jones Hill Capital first reported a position in ANI Pharmaceuticals in Q1 2026 and held it in 2 quarters.
  • Jones Hill Capital's ANI Pharmaceuticals position peaked at $24.5M in Q1 2026.
  • 291 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Jones Hill Capital's 13F filing for Q3 2026, filed 13 Nov 2026.